Literature DB >> 3196050

Biotinidase deficiency: a survey of 10 cases.

H J Wastell1, K Bartlett, G Dale, A Shein.   

Abstract

Ten patients with biotinidase deficiency were studied. Clinical findings at presentation varied with dermatological signs (dermatitis and alopecia), neurological abnormalities (fits, hypotonia, and ataxia), and recurrent infections being the most common features, although none of these occurred in every case. Biochemically the disease is characterised by metabolic acidosis and organic aciduria. Treatment with biotin results in pronounced, rapid, clinical and biochemical improvement, but some patients have residual neurological damage comprising neurosensory hearing loss, visual pathway defects, ataxia, and mental retardation. The cause of this permanent damage remains obscure and it is not clear if the early introduction of treatment will prevent it.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196050      PMCID: PMC1779020          DOI: 10.1136/adc.63.10.1244

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  Leigh's encephalomyelopathy: an inborn error of gluconeogenesis.

Authors:  F A Hommes; H A Polman; J D Reerink
Journal:  Arch Dis Child       Date:  1968-08       Impact factor: 3.791

2.  Pathogenesis of Leigh's encephalomyelopathy.

Authors:  T T Tang; T A Good; P R Dyken; S D Johnsen; S R McCreadie; S T Sy; H A Lardy; F B Rudolph
Journal:  J Pediatr       Date:  1972-07       Impact factor: 4.406

3.  Acetyl-CoA carboxylase deficiency: an inborn error of de novo fatty acid synthesis.

Authors:  W Blom; S M de Muinck Keizer; H R Scholte
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

4.  Studies on cultured fibroblasts from patients with defects of biotin-dependent carboxylation.

Authors:  K Bartlett; H Ng; G Dale; A Green; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

5.  Does screening by "Pap" smears help prevent cervical cancer? A case-control study.

Authors:  E A Clarke; T W Anderson
Journal:  Lancet       Date:  1979-07-07       Impact factor: 79.321

6.  Pyruvate carboxylase and phosphoenolpyruvate carboxykinase activity in leukocytes and fibroblasts from a patient with pyruvate carboxylase deficiency.

Authors:  B M Atkin; M F Utter; M B Weinberg
Journal:  Pediatr Res       Date:  1979-01       Impact factor: 3.756

7.  Phenotypic variation in biotinidase deficiency.

Authors:  B Wolf; R E Grier; R J Allen; S I Goodman; C L Kien; W D Parker; D M Howell; D L Hurst
Journal:  J Pediatr       Date:  1983-08       Impact factor: 4.406

8.  Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency.

Authors:  B Wolf; R E Grier; R J Allen; S I Goodman; C L Kien
Journal:  Clin Chim Acta       Date:  1983-07-15       Impact factor: 3.786

9.  Mutant holocarboxylase synthetase: evidence for the enzyme defect in early infantile biotin-responsive multiple carboxylase deficiency.

Authors:  B J Burri; L Sweetman; W L Nyhan
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

10.  Inherited disorders of 3-methylcrotonyl CoA carboxylation.

Authors:  J V Leonard; J W Seakins; K Bartlett; J Hyde; J Wilson; B Clayton
Journal:  Arch Dis Child       Date:  1981-01       Impact factor: 3.791

View more
  18 in total

1.  Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases.

Authors:  T Baykal; G Gokcay; Y Gokdemir; F Demir; Y Seckin; M Demirkol; K Jensen; B Wolf
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Comparison of patients with complete and partial biotinidase deficiency: biochemical studies.

Authors:  T M Suormala; E R Baumgartner; H Wick; S Scheibenreiter; S Schweitzer
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Biotinidase deficiency.

Authors:  Rps Tomar; D Vashisth; R Vasudevan
Journal:  Med J Armed Forces India       Date:  2012-01-18

Review 4.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

5.  Cerebral metabolic change after treatment in biotinidase deficiency.

Authors:  I T Lott; S Lottenberg; W L Nyhan; M J Buchsbaum
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Biotinidase Km-variants: detection and detailed biochemical investigations.

Authors:  T Suormala; V T Ramaekers; S Schweitzer; B Fowler; M C Laub; C Schwermer; J Bachmann; E R Baumgartner
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Biotinidase deficiency--clinching the diagnosis rapidly can make all the difference!

Authors:  Ashwin Rajendiran; Sowmya Sampath
Journal:  BMJ Case Rep       Date:  2011-09-28

8.  A biotinidase Km variant causing late onset bilateral optic neuropathy.

Authors:  V T Ramaekers; T M Suormala; M Brab; R Duran; G Heimann; E R Baumgartner
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

9.  Neuropathology of biotinidase deficiency.

Authors:  M Honavar; I Janota; B G Neville; R A Chalmers
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Biotinidase deficiency mimicking primary immune deficiencies.

Authors:  Ertugrul Kiykim; Ayca Kiykim; Mehmet Serif Cansever; Cigdem Ayse Aktuglu Zeybek
Journal:  BMJ Case Rep       Date:  2015-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.